ew drugs for treatment of depressio
Not Applicable
Completed
- Conditions
- Health Condition 1: F332- Major depressive disorder, recurrent severe without psychotic featuresHealth Condition 2: F331- Major depressive disorder, recurrent, moderate
- Registration Number
- CTRI/2022/07/043818
- Lead Sponsor
- Simple Santi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 96
Inclusion Criteria
1. Patients with MDD
2. HDRS score > 24 at baseline
3. Patients willing to give written informed consent at baseline
Exclusion Criteria
1. Patients with psychotic symptoms
2. Patients with a history of substance abuse
3. Pregnant or lactating women
4. Patient with a history of known adverse effect to the study drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of HDRS score by 15 units in at least 50% of participants in the study groupsTimepoint: Baseline, Week 16
- Secondary Outcome Measures
Name Time Method